Premium
Phenylbutazone in horses and man: Properties relevant to safety of humans consuming horse meat containing phenylbutazone and its metabolites
Author(s) -
Lees P.,
Toutain P.L.
Publication year - 2013
Publication title -
equine veterinary education
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 31
eISSN - 2042-3292
pISSN - 0957-7734
DOI - 10.1111/eve.12112
Subject(s) - phenylbutazone , horse , pharmacology , medicine , cyclooxygenase , donkey , prostaglandin e2 , equidae , inflammation , chemistry , biochemistry , enzyme , biology , paleontology , ecology
This editorial assesses the potential toxicity for human individuals consuming equine muscle containing phenylbutazone and its metabolites, in trace amounts, by reviewing: 1) the pharmacokinetic, pharmacodynamic, metabolic and toxicological profiles of phenylbutazone in horses and man; 2) phenylbutazone residues in equine muscle; 3) the extent of consumption of equine meat, containing phenylbutazone or not; and 4) the moves being made towards improving the equine passport system. This editorial summarises and extends the contents of a recent review (Lees and Toutain 2013).